Janus Biotherapeutics is a project-oriented biopharmaceutical company progressing a series of small-molecule leads for the treatment of autoimmune diseases. The company is based in the Boston area (Wellesley, MA). Janus focuses its financial and managerial resources on the preclinical development of its lead programs. Its core work centers on advancing preclinical small-molecule candidates toward development. The company has initiated an equity financing to support these programs. According to SEC filings, it has raised $1.1M of a planned $3M equity financing from six investors to date.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2011